目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global herpes treatment market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global herpes treatment market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Vaccination - Market size and forecast 2022-2027
Exhibit 34: Chart on Vaccination - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Vaccination - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Vaccination - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Vaccination - Year-over-year growth 2022-2027 (%)
6.4 Drug therapy - Market size and forecast 2022-2027
Exhibit 38: Chart on Drug therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Drug therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Drug therapy - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Drug therapy - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 43: Chart on Type - Market share 2022-2027 (%)
Exhibit 44: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 45: Chart on Comparison by Type
Exhibit 46: Data Table on Comparison by Type
7.3 Herpes zoster - Market size and forecast 2022-2027
Exhibit 47: Chart on Herpes zoster - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Herpes zoster - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Herpes zoster - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Herpes zoster - Year-over-year growth 2022-2027 (%)
7.4 Herpes simplex - Market size and forecast 2022-2027
Exhibit 51: Chart on Herpes simplex - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Herpes simplex - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Herpes simplex - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Herpes simplex - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 55: Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 59: Chart on Geographic comparison
Exhibit 60: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Japan - Market size and forecast 2022-2027
Exhibit 81: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 France - Market size and forecast 2022-2027
Exhibit 89: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on France - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 97: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 98: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 100: Overview on factors of disruption
11.4 Industry risks
Exhibit 101: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 102: Vendors covered
12.2 Market positioning of vendors
Exhibit 103: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 104: AbbVie Inc. - Overview
Exhibit 105: AbbVie Inc. - Product / Service
Exhibit 106: AbbVie Inc. - Key news
Exhibit 107: AbbVie Inc. - Key offerings
12.4 AiCuris Anti infective Cures AG
Exhibit 108: AiCuris Anti infective Cures AG - Overview
Exhibit 109: AiCuris Anti infective Cures AG - Product / Service
Exhibit 110: AiCuris Anti infective Cures AG - Key offerings
12.5 Aurobindo Pharma Ltd.
Exhibit 111: Aurobindo Pharma Ltd. - Overview
Exhibit 112: Aurobindo Pharma Ltd. - Product / Service
Exhibit 113: Aurobindo Pharma Ltd. - Key offerings
12.6 Cadila Healthcare Ltd.
Exhibit 114: Cadila Healthcare Ltd. - Overview
Exhibit 115: Cadila Healthcare Ltd. - Business segments
Exhibit 116: Cadila Healthcare Ltd. - Key news
Exhibit 117: Cadila Healthcare Ltd. - Key offerings
Exhibit 118: Cadila Healthcare Ltd. - Segment focus
12.7 Cipla Ltd.
Exhibit 119: Cipla Ltd. - Overview
Exhibit 120: Cipla Ltd. - Business segments
Exhibit 121: Cipla Ltd. - Key news
Exhibit 122: Cipla Ltd. - Key offerings
Exhibit 123: Cipla Ltd. - Segment focus
12.8 Eli Lilly and Co.
Exhibit 124: Eli Lilly and Co. - Overview
Exhibit 125: Eli Lilly and Co. - Product / Service
Exhibit 126: Eli Lilly and Co. - Key offerings
12.9 Fresenius SE and Co. KGaA
Exhibit 127: Fresenius SE and Co. KGaA - Overview
Exhibit 128: Fresenius SE and Co. KGaA - Business segments
Exhibit 129: Fresenius SE and Co. KGaA - Key news
Exhibit 130: Fresenius SE and Co. KGaA - Key offerings
Exhibit 131: Fresenius SE and Co. KGaA - Segment focus
12.10 Gilead Sciences Inc.
Exhibit 132: Gilead Sciences Inc. - Overview
Exhibit 133: Gilead Sciences Inc. - Product / Service
Exhibit 134: Gilead Sciences Inc. - Key news
Exhibit 135: Gilead Sciences Inc. - Key offerings
12.11 GlaxoSmithKline Plc
Exhibit 136: GlaxoSmithKline Plc - Overview
Exhibit 137: GlaxoSmithKline Plc - Business segments
Exhibit 138: GlaxoSmithKline Plc - Key offerings
Exhibit 139: GlaxoSmithKline Plc - Segment focus
12.12 Maruho Co. Ltd.
Exhibit 140: Maruho Co. Ltd. - Overview
Exhibit 141: Maruho Co. Ltd. - Product / Service
Exhibit 142: Maruho Co. Ltd. - Key offerings
12.13 Merck and Co. Inc.
Exhibit 143: Merck and Co. Inc. - Overview
Exhibit 144: Merck and Co. Inc. - Business segments
Exhibit 145: Merck and Co. Inc. - Key news
Exhibit 146: Merck and Co. Inc. - Key offerings
Exhibit 147: Merck and Co. Inc. - Segment focus
12.14 Novartis AG
Exhibit 148: Novartis AG - Overview
Exhibit 149: Novartis AG - Business segments
Exhibit 150: Novartis AG - Key offerings
Exhibit 151: Novartis AG - Segment focus
12.15 Sun Pharmaceutical Industries Ltd.
Exhibit 152: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 153: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 154: Sun Pharmaceutical Industries Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 155: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 156: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 157: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 158: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 159: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Exhibit 160: Viatris Inc. - Overview
Exhibit 161: Viatris Inc. - Business segments
Exhibit 162: Viatris Inc. - Key offerings
Exhibit 163: Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 164: Inclusions checklist
Exhibit 165: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 166: Currency conversion rates for US$
13.4 Research methodology
Exhibit 167: Research methodology
Exhibit 168: Validation techniques employed for market sizing
Exhibit 169: Information sources
13.5 List of abbreviations
Exhibit 170: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global herpes treatment market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Vaccination - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Vaccination - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Vaccination - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Vaccination - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Drug therapy - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Drug therapy - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Drug therapy - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Drug therapy - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Chart on Type - Market share 2022-2027 (%)
Exhibits44: Data Table on Type - Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Type
Exhibits46: Data Table on Comparison by Type
Exhibits47: Chart on Herpes zoster - Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Herpes zoster - Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Herpes zoster - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Herpes zoster - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Herpes simplex - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Herpes simplex - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Herpes simplex - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Herpes simplex - Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Type ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity By Geographical Landscape ($ million)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: AbbVie Inc. - Overview
Exhibits105: AbbVie Inc. - Product / Service
Exhibits106: AbbVie Inc. - Key news
Exhibits107: AbbVie Inc. - Key offerings
Exhibits108: AiCuris Anti infective Cures AG - Overview
Exhibits109: AiCuris Anti infective Cures AG - Product / Service
Exhibits110: AiCuris Anti infective Cures AG - Key offerings
Exhibits111: Aurobindo Pharma Ltd. - Overview
Exhibits112: Aurobindo Pharma Ltd. - Product / Service
Exhibits113: Aurobindo Pharma Ltd. - Key offerings
Exhibits114: Cadila Healthcare Ltd. - Overview
Exhibits115: Cadila Healthcare Ltd. - Business segments
Exhibits116: Cadila Healthcare Ltd. - Key news
Exhibits117: Cadila Healthcare Ltd. - Key offerings
Exhibits118: Cadila Healthcare Ltd. - Segment focus
Exhibits119: Cipla Ltd. - Overview
Exhibits120: Cipla Ltd. - Business segments
Exhibits121: Cipla Ltd. - Key news
Exhibits122: Cipla Ltd. - Key offerings
Exhibits123: Cipla Ltd. - Segment focus
Exhibits124: Eli Lilly and Co. - Overview
Exhibits125: Eli Lilly and Co. - Product / Service
Exhibits126: Eli Lilly and Co. - Key offerings
Exhibits127: Fresenius SE and Co. KGaA - Overview
Exhibits128: Fresenius SE and Co. KGaA - Business segments
Exhibits129: Fresenius SE and Co. KGaA - Key news
Exhibits130: Fresenius SE and Co. KGaA - Key offerings
Exhibits131: Fresenius SE and Co. KGaA - Segment focus
Exhibits132: Gilead Sciences Inc. - Overview
Exhibits133: Gilead Sciences Inc. - Product / Service
Exhibits134: Gilead Sciences Inc. - Key news
Exhibits135: Gilead Sciences Inc. - Key offerings
Exhibits136: GlaxoSmithKline Plc - Overview
Exhibits137: GlaxoSmithKline Plc - Business segments
Exhibits138: GlaxoSmithKline Plc - Key offerings
Exhibits139: GlaxoSmithKline Plc - Segment focus
Exhibits140: Maruho Co. Ltd. - Overview
Exhibits141: Maruho Co. Ltd. - Product / Service
Exhibits142: Maruho Co. Ltd. - Key offerings
Exhibits143: Merck and Co. Inc. - Overview
Exhibits144: Merck and Co. Inc. - Business segments
Exhibits145: Merck and Co. Inc. - Key news
Exhibits146: Merck and Co. Inc. - Key offerings
Exhibits147: Merck and Co. Inc. - Segment focus
Exhibits148: Novartis AG - Overview
Exhibits149: Novartis AG - Business segments
Exhibits150: Novartis AG - Key offerings
Exhibits151: Novartis AG - Segment focus
Exhibits152: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits153: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits154: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits155: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits156: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits157: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits158: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits159: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits160: Viatris Inc. - Overview
Exhibits161: Viatris Inc. - Business segments
Exhibits162: Viatris Inc. - Key offerings
Exhibits163: Viatris Inc. - Segment focus
Exhibits164: Inclusions checklist
Exhibits165: Exclusions checklist
Exhibits166: Currency conversion rates for US$
Exhibits167: Research methodology
Exhibits168: Validation techniques employed for market sizing
Exhibits169: Information sources
Exhibits170: List of abbreviations